Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 136
Selected: 0
NCT IDTitle
NCT01221597Study of AA4500 in the Treatment of Peyronie's Disease
NCT00637572Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
NCT00226395Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain
NCT00903851Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy
NCT00954746Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
NCT00846495Pilot Study to Compare Frovatriptan vs. Topiramate for Prevention of Migraine
NCT01430169Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease
NCT02006680Markers of Pubertal Suppression During Therapy for Precocious Puberty
NCT01715467CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment
NCT00414453Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis
NCT01310803Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
NCT03526549Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)
NCT01221623Study of AA4500 in the Treatment of Peyronie's Disease
NCT01407068Administration of Two Injections for Multiple Dupuytren's Contractures
NCT00528424AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease
NCT01685437A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease
NCT01784757Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer
NCT04677712Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite
NCT04680156Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)
NCT00913055Open Label Study of Octreotide Implant in Patients With Acromegaly
NCT01697384Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer
NCT05877066Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
NCT05873595Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease
NCT05254457Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis
NCT02006719Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
NCT00528931A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture
NCT00904085Post-operative Efficacy and Safety Study
NCT01035983Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches
NCT00904280Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy
NCT00904202A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
NCT00652093Lumbar Stenosis Outcomes Research II
NCT04236635Histopathology Following CCH Injection
NCT01206907Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects
NCT01114711Frovatriptan and Menstrual Migraine
NCT03675685Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP
NCT00904475Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain
NCT02267460An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease
NCT01086150Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy
NCT04093050Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers
NCT01317641Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
NCT01515540Brain Imaging of Lidoderm for Chronic Back Pain
NCT00765856Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
NCT03120351Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery
NCT00226421Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
NCT00904098Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
NCT00904111A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain
NCT00911287Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain
NCT01606345Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma
NCT02687451Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
NCT01674634Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures